Marcea Bland Lloyd
CIK 1389208 · SVP, Chief Administrative Offi · last filed 2025-01-08
Marcea Bland Lloyd is a SVP, Chief Administrative Offi who has filed 20 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for PSTX, was dated Jan 8, 2025. Across all open-market trades the lifetime net is −$93.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
20
-$93.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $160.0K | 8 | 2025-01-08 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | SVP, Chief Administrative Offi | 64,556 | — | — | -$253.5K | 11 | 2012-03-07 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-08 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | −68,950 | $0 | EDGAR |
| 2024-06-18 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +19,650 | $0 | EDGAR |
| 2023-06-16 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +19,650 | $0 | EDGAR |
| 2022-06-16 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +19,650 | $0 | EDGAR |
| 2021-07-26 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-15 | Poseida Therapeutics, Inc. (PSTX) Delisted | Buy (P) | +10,000 | $160.0K | EDGAR |
| 2020-07-13 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-10 | — | Mixed | −72,530 | -$2.25M | |
| 2012-03-07 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | +11,529 | $0 | EDGAR |